GGrantIndex
← Leaderboards

Flavio Vincenti

University Of California San Francisco

$15,185,072
Attributed
$15,185,072
Total exposure
2
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.4M · FY200523
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$15,185,072 · 2

By mechanism

U01$15,179,927 · 1
M01$5,145 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Chronic

Research focus

ChronicTransplant RecipientsKidneyCellsResponseT-LymphocyteGraft SurvivalInterleukin 6 ReceptorPreventPathway InteractionsRandomizedRegimenAntibodiesSafetyAntigensCessation Of LifeAutologousInfusion ProceduresMediatingKidney TransplantationOrgan TransplantationBaseNovel TherapeuticsBiopsy

Grant awards (11)

Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)$634,397
U01 · FY2023 · AI · contact PI
Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)$819,899
U01 · FY2022 · AI · contact PI
Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)$1
U01 · FY2021 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$559,395
U01 · FY2020 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$1,259,989
U01 · FY2019 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$2,339,148
U01 · FY2018 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$2,370,047
U01 · FY2017 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$2,383,582
U01 · FY2016 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$2,394,018
U01 · FY2015 · AI · contact PI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts$2,419,451
U01 · FY2014 · AI · contact PI
THE EFFECT OF RITUXIMAB ON THE DEVELOPMENT OF ANTI DONOR ANTIBODIES AND RESOL$5,145
M01 · FY2005 · RR